Some measures of success continued to improve in men with type 2 diabetes on testosterone replacement therapy. Others reverted to the norm of the placebo group. The abstract says:
"Improvement in HbA1c and weight at the end of the RCT [randomized clinical trial] and open-label phase in men on...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.